Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04513665 · ClinicalTrials.gov registry record · Phase 2
ZW25 in Women With Endometrial Cancers
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT04513665: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04513665 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04513665, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is being done to test the drug ZW25 and look at whether this drug is effective in women with HER2-overexpressed endometrial cancer or carcinosarcoma that has been treated in the past.
Interventions
- DRUG ZW25
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2024-03-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04513665
The ClinicalTrials.gov registry entry for NCT04513665 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZW25 is the first listed.
NCT04513665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04513665 about?
NCT04513665 is a clinical study titled "ZW25 in Women With Endometrial Cancers". This study is being done to test the drug ZW25 and look at whether this drug is effective in women with HER2-overexpressed endometrial cancer or carcinosarcoma that has been treated in the past.
What is the current status of trial NCT04513665?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2020-08-12. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT04513665?
The interventions under investigation include: ZW25 (DRUG).
Who is sponsoring clinical trial NCT04513665?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.